Commonwealth Equity Services’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-37,905
| Closed | -$25K | – | 3986 |
|
|
2023
Q2 | $25K | Buy |
37,905
+20
| +0.1% | +$13 | ﹤0.01% | 3735 |
|
|
2023
Q1 | $52 | Sell |
37,885
-256
| -0.7% | – | ﹤0.01% | 3580 |
|
|
2022
Q4 | $48K | Buy |
38,141
+18,411
| +93% | +$23.2K | ﹤0.01% | 3521 |
|
|
2022
Q3 | $84K | Buy |
19,730
+5,210
| +36% | +$22.2K | ﹤0.01% | 3403 |
|
|
2022
Q2 | $75K | Buy |
14,520
+4,000
| +38% | +$20.7K | ﹤0.01% | 3422 |
|
|
2022
Q1 | $126K | Buy |
10,520
+1,915
| +22% | +$22.9K | ﹤0.01% | 3440 |
|
|
2021
Q4 | $168K | Buy |
8,605
+952
| +12% | +$18.6K | ﹤0.01% | 3350 |
|
|
2021
Q3 | $198K | Buy |
7,653
+3,853
| +101% | +$99.7K | ﹤0.01% | 3281 |
|
|
2021
Q2 | $83K | Buy |
3,800
+170
| +5% | +$3.71K | ﹤0.01% | 3426 |
|
|
2021
Q1 | $84K | Buy |
3,630
+2,875
| +381% | +$66.5K | ﹤0.01% | 3295 |
|
|
2020
Q4 | $12K | Buy |
+755
| New | +$12K | ﹤0.01% | 3186 |
|